VICO.ST STO
Vicore Pharma Holding AB (publ)
1W: -2.9%
1M: -14.5%
3M: -40.6%
YTD: -14.2%
1Y: -14.3%
3Y: -37.4%
5Y: -53.5%
kr 9.32 ($0.93)
-0.09 (-0.96%)
Weekly Expected Move ±5.1%
kr 8
kr 9
kr 9
kr 10
kr 10
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$1.2B
+1.4% ▲
5Y CAGR: +24.6%
Total Liabilities
$124M
+68.3% ▲
5Y CAGR: +19.0%
Shareholders Equity
$1.1B
-3.0% ▼
5Y CAGR: +25.3%
Cash & Investments
$1.2B
+1.1% ▲
5Y CAGR: +29.7%
Total Debt
$0
+0.0% ▲
Net Debt
-$578M
+50.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $294M | $257M | $334M | $1.2B | $578M |
| Short-Term Investments | $77M | $5M | $149M | $0 | $590M |
| Cash & ST Investments | $371M | $262M | $483M | $1.2B | $1.2B |
| Net Receivables | $2M | $2M | $3M | $20M | $14M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $2M | $3M | $0 | $2M |
| Total Current Assets | $378M | $270M | $496M | $1.2B | $1.2B |
| Property, Plant & Equip. | $84K | $54K | $25K | $0 | $0 |
| Goodwill & Intangibles | $67M | $68M | $2M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $2M |
| Other Non-Current Assets | $77M | $63K | $0 | $0 | -$2M |
| Total Non-Current Assets | $73M | $68M | $2M | $0 | $0 |
| Total Assets | $451M | $338M | $498M | $1.2B | $1.2B |
| — Liabilities — | |||||
| Accounts Payable | $24M | $23M | $18M | $30M | $39M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $5M | $8M | $35M | $79M |
| Total Current Liabilities | $66M | $46M | $41M | $73M | $118M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $600K | $2M | $898K | $556K | $6M |
| Total Non-Current Liabilities | $2M | $3M | $1M | $871K | $6M |
| Total Liabilities | $68M | $49M | $42M | $74M | $124M |
| — Equity — | |||||
| Common Stock | $36M | $41M | $56M | $117M | $141M |
| Retained Earnings | -$674M | -$963M | -$1.3B | -$1.4B | $0 |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | $383M | $289M | $455M | $1.1B | $1.1B |
| Total Liabilities & Equity | $451M | $338M | $498M | $1.2B | $1.2B |
| — Key Metrics — | |||||
| Total Debt | $320K | $65K | $0 | $0 | $0 |
| Net Debt | -$294M | -$257M | -$334M | -$1.2B | -$578M |
| Total Investments | $5M | $5M | $149M | $0 | $592M |